Mapping the SF-12 to preference-based instruments: Convergent validity in a low-income, minority population

Medical Care

Volumn 41, Issue 11, 2003, Pages 1277-1283

  Franks, Peter ^a   Lubetkin, Erica I ^b   Gold, Marthe R ^b   Tancredi, Daniel J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^c Center for Health Services Research in Primary Care   (United States)

Author keywords

EQ 5D; Health status; HUI Mark 3; Low income; Minority; SF 12

Indexed keywords

ABORIGINE; ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CAUCASIAN; COMMUNITY CARE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; EDUCATION; FEMALE; HEALTH STATUS; HEALTH SURVEY; HISPANIC; HUMAN; INCOME; MALE; MIDDLE AGED; MINORITY GROUP; PILOT STUDY; QUESTIONNAIRE; VALIDATION STUDY;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COMMUNITY HEALTH SERVICES; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; EDUCATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HISPANIC AMERICANS; HUMANS; INCOME; MALE; MIDDLE AGED; MINORITY GROUPS; OCEANIC ANCESTRY GROUP; PILOT PROJECTS; QUESTIONNAIRES;

EID: 0642372940     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MLR.0000093480.58308.D8     Document Type: Article

References (29)

1. Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 System. Med Care 2002;40:113-128.
2. Dolan P, Roberts J. Modelling valuations for Eq-5d health states: an alternative model using differences in valuations. Med Care 2002;40:442-446.
3. Gold MR, Siegel JE, Russell LE, et al., eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
4. Lenert LA, Sherbourne CD, Sugar C, et al. Estimation of utilities for the effects of depression from the SF-12. Med Care 2000;38:763-770.
5. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-292.
6. Fryback DG, Lawrence WF, Martin PA, et al. Predicting Quality of well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study. Med Decis Making 1997;17:1-9.
7. Nichol MB, Sengupta N, Globe DR. Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36. Med Decis Making 2001;21:105-112.
8. Shmueli A. Subjective health status and health values in the general population. Med Decis Making 1999;19:122-127.
9. Lundberg L, Johannesson M, Isacson DG, et al. The relationship between health-state utilities and the SF-12 in a general population. Med Decis Making 1999;19:128-140.
10. Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project (International Quality of Life Assessment). J Clin Epidemiol 1998;51:1171-1178.
11. Lubetkin EI, Gold MR. Comprehensibility of measures of health-related quality of life in minority and low-income patients. J Natl Med Assoc 2002;94:327-335.
12. Ware JE, Kosinski M, Keller SD. How to Score the SF-12® Physical and Mental Health Summary Scales, 3rd ed. Lincoln, RI: QualityMetric Inc; 1998.
13. Ware JE Jr, Kosinski M, Keller SD. A 12-item short-form health survey. Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
14. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-1108.
15. Kind P. The EuroQol instrument: an index of health-related quality of life. In: Spilker B, ed. Quality of life and Pharmacoeconomics in Clinical Trials, 2nd ed. Philadelphia: Lippincott-Raven; 1996:191-201.
16. Hisashige A, Mikasa H, Katayama T. Description and valuation of health-related quality of life among the general public in Japan by the EuroQol. J Med Invest 1998;45:123-129.
17. Johnson JA, Coons SJ, Ergo A, et al. Valuation of EuroQOL (EQ-5D) health states in an adult US Sample. Pharmacoeconomics 1998;13:421-433.
18. Hurst NP, Kind P, Ruta D, et al. Measuring ealth-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997;36:551-559.
19. Brazier J, Jones N, Kind P. Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993;2:169-180.
20. Badia X, Schiaffino A, Alonso J, et al. Using the EuroQol 5-D in the Catalan general population: Dasibility and construct validity. Qual Life Res 998;7:311-322.
21. Barr RD, Gonzalez A, Longchong M, et al. Health status and health-related quality of life in survivors of cancer in childhood in Latin America: a MISPHO dasibility study. Int J Oncol 2001;19:413-421.
22. Stata Statistical Software, release 8.0. College station, TX: Stata Corp; 2003.
23. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.
24. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York: Capman & Hill; 1993.
25. MacKinnon JG, White H. Some heteroscedasticity consistent covariance matrix estimators with improved finite sample properties. Journal of Econometrics 1985;29:305-325.
26. Johnson JA, Pickard AS. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care 2000;38:115-121.
27. Cohen J, Cohen F. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1983.
28. Ren XS, Amick BC. Racial and ethnic disparities in self-assessed health status: evidence from the National Survey of Families and Households. Ethn Health 1996;1:293-303.
29. Burdine JN, Felix MR, Abel AL, et al. The SF-12 as a population health measure: an exploratory examination of potential for application. Health Serv Res 2000;35:885-904.